logo

Last Update

This profile was last updated on 9/12/2006 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Jerry Jackson?

Jerry T. Jackson

Director

Myogen , Inc.

HQ Phone:  (303) 410-6666

Email: j***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Myogen , Inc.

7575 W. 103Rd Avenue, Suite 102

Westminster, Colorado,80021

United States

Company Description

Myogen has two product candidates in late-stage clinical development: ambrisentan for the treatment of patients with pulmonary arterial hypertension (PAH) and darusentan for the treatment of patients with resistant hypertension. Myogen and GlaxoSmithKline have...more

Background Information

Employment History

Director

Molecular Biosystems , Inc.


Executive Vice President

Merck & Co. , Inc.


Affiliations

Alexion Pharmaceuticals Inc

Board Member


MD EDGE , Inc.

Board Member


corr.com

Board Member


Alpharma Inc.

Board Member


IntraBiotics Pharmaceuticals , Inc.

Board Member


COR Therapeutics , Inc.

Board Member


ALZA Corporation

Board Member


Education

MD EDGE , Inc.


bachelor of arts degree

University of New Mexico


Web References(39 Total References)


www.sec.gov

0001065163 JACKSON JERRY T 7212 NORTH SECRET CANYON DRIVE TUCSON AZ 85718 1 0 0 0


investor.myogen.com [cached]

Jerry T. JacksonMyogen, Inc.: Investor Relations: BiographyJerry T. JacksonDirectorMr. Jackson has served as a Director since September 2002.Mr. Jackson was employed by Merck & Co., Inc., a pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until retirement, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups - including being President of Merck's Worldwide Human Health Division in 1993 and Senior Vice President responsible for Merck's Specialty Chemicals Business in 1991 to 1992.Previously, he was President of Merck's International Division from 1988 to 1991.Mr. Jackson has served on the board of directors of several biotech pharmaceutical companies and currently is on the board of Alexion Pharmaceuticals, Inc. and Intrabiotics Pharmaceuticals, Inc.Mr. Jackson received a B.A. in Education from the University of New Mexico in 1964.


www.sec.gov [cached]

Other than Dr. Bristow and Mr. Jackson, all of the directors attended the 2004 Annual Meeting of Stockholders in person or via teleconference.Jerry T. Jackson Jerry T. Jackson.Mr. Jackson has served as a Director since September 2002.Mr. Jackson was employed by Merck & Co., Inc., a pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until retirement, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups, including being President of Merck's Worldwide Human Health Division in 1993.Mr. Jackson was Senior Vice President responsible for Merck's Specialty Chemicals Business from 1991 to 1992.Previously, he was President of Merck's International Division from 1988 to 1991.Mr. Jackson has served on the board of directors of several biotech pharmaceutical companies and currently is on the board of Intrabiotics Pharmaceuticals, Inc.Mr. Jackson holds a B.A. in Education from the University of New Mexico.


www.sec.gov [cached]

Jerry T. Jackson(1)(2)(3)Jerry T. Jackson.Mr. Jackson has served as a director of IntraBiotics since August 2002.Mr. Jackson is currently and has been retired since 1995.Mr. Jackson was employed by Merck & Co., Inc., a major pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until retirement, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups, including being President of Merck's Worldwide Human Health Division in 1993 and Senior Vice President responsible for Merck's Specialty Chemicals Business from 1991 to 1992.Previously, he was President of Merck's International Division.Mr. Jackson has served on the board of directors of several biotech pharmaceutical companies and currently serves as a director of Myogen, Inc.Mr. Jackson received a B.A. degree in Education from the University of New Mexico in 1964. Three directors comprise the Audit Committee: Mr. Perry, Mr. Lyons and Mr. Jackson.Three directors comprise the Compensation Committee: Mr. Lyons, Mr. Perry, and Mr. Jackson.Three directors comprise the Nominating and Corporate Governance Committee: Dr. Mario, Mr. Jackson and Mr. Perry.


www.sec.gov

Jerry T. Jackson (2)(3)Jerry T. Jackson has been a director of Alexion since September 1999.He was employed by Merck & Co.Inc., a major pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until 1995, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups including Merck's International Human Health, Worldwide Human Vaccines, the AgVet Division, Astra/Merck U.S. Operations, as well as worldwide marketing.During 1993, he was also President of the Worldwide Human Health Division.He served as Senior Vice President of Merck from 1991 to 1992 responsible for Merck's Specialty Chemicals and previously, he was President of Merck's Sharp & Dohme International.Mr. Jackson serves as a director of Langford I.C. Systems, Inc., IntraBiotics Pharmaceuticals, Inc., and Myogen, Inc., each a small pharmaceutical company.He received his B.A. from University of New Mexico.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory